La cadena de opciones muestra datos clave de las opciones de acciones de NewGenIvf Group a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para NewGenIvf Group..

NewGenIvf Group (NASDAQ:NIVF) Bolsa, Cadena de Opciones

NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.

Earnings

News

Markets

Trading Ideas

APDN

AUID

CERO

COMM

CRVS

EFSH

FSBW

NIVF

NUKK

PRTG

PRZO

PTPI

RZLV

SHLT

SSBK

TNXP

VSTE

Acciones de Corvus suben un 22,5% pre-market tras anunciar datos de Soquelitinib. Descubre más ganadores y perdedores.

Acciones de Corvus Pharmaceuticals (CRVS) suben alrededor del 22%; 20 acciones que se mueven en premercado

NewGenIvf Group Limited - Class A Ordinary Shares

NewGenIvf Group Ltd

Financial Outlook
BlackBerry is providing the following guidance for the first fiscal quarter and the full fiscal year 2026 (ending February 28, 2026).
<figure class="table"> 
<table>
<tbody>
<tr>
<td>&nbsp;</td>
<td>Q1 FY26</td>
<td>Full fiscal year FY26</td>
</tr>
<tr>
<td>Total BlackBerry revenue:</td>
<td>$107 - $115 million</td>
<td>$504 - $534 million</td>
</tr>
<tr>
<td>QNX revenue:</td>
<td>$51 - $55 million</td>
<td>$250 - $270 million</td>
</tr>
<tr>
<td>Secure Communications revenue:</td>
<td>$50 - $54 million</td>
<td>$230 - $240 million</td>
</tr>
<tr>
<td>Licensing revenue:</td>
<td>Approximately $6 million</td>
<td>Approximately $24 million</td>
</tr>
<tr>
<td>QNX segment adjusted EBITDA:</td>
<td>$2 - $6 million</td>
<td>$55 - $60 million</td>
</tr>
<tr>
<td>Secure Communications segment</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>adjusted EBITDA:</td>
<td>$3 - $6 million</td>
<td>$34 - $44 million</td>
</tr>
<tr>
<td>Licensing segment adjusted EBITDA:</td>
<td>Approximately $5 million</td>
<td>Approximately $20 million</td>
</tr>
<tr>
<td>Adjusted Corporate Costs:</td>
<td>Approximately $10 million</td>
<td>Approximately $40 million</td>
</tr>
<tr>
<td>Total Company adjusted EBITDA:</td>
<td>Breakeven - $7 million</td>
<td>$69 - $84 million</td>
</tr>
<tr>
<td>Non-GAAP basic EPS:</td>
<td>($0.01) - Breakeven</td>
<td>$0.08 - $0.10</td>
</tr>
<tr>
<td>Operating cash flow (usage)</td>
<td>($20) - ($30) million</td>
<td>Approximately $35 million</td>
</tr>
</tbody>
</table>
</figure>

Guidance

BlackBerry Now Expects FY26 Total Revenue Of $504M-$534M Vs $546.34M Est, Adj EPS Of $0.08-$0.10 Vs $0.10 Est

HC Wainwright &amp; Co. analyst Matthew Caufield maintains Mineralys Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLYS#NASDAQ">MLYS</a>) with a Buy and raises the price target from $30 to $42.

Price Target

Analyst Ratings

MLYS

HC Wainwright & Co. Maintains Buy on Mineralys Therapeutics, Raises Price Target to $42

Telsey Advisory Group analyst Dana Telsey maintains Macy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/M#NYSE">M</a>) with a Market Perform and maintains $15 price target.

Telsey Advisory Group Maintains Market Perform on Macy's, Maintains $15 Price Target

As a result, the company expects first quarter 2025 Adjusted Profit Before Tax&nbsp;in a range of $92.3 to $97.3 million (Q1 2024: $67.7 million).
 &nbsp;

Marex Group Expects Q1 Revenues $449.3M - $464.3M, Est $421.573M; Adj EPS Of $0.88 - $0.93, Est $0.77

BRKR

Bruker Announces Introduction Of d-DNP Polarizer For MRI Research And For Dynamic Nuclear Polarization Liquids NMR

HC Wainwright &amp; Co. analyst Matthew Caufield reiterates Surrozen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRZN#NASDAQ">SRZN</a>) with a Buy and maintains $32 price target.

Reiteration

SRZN

HC Wainwright & Co. Reiterates Buy on Surrozen, Maintains $32 Price Target

Republic National Distribution Company opens new distribution channels in six states including California, one of the largest markets in the U.S.

Innovation Beverage Group Expands U.S. Reach With Republic National Distribution Company Distribution Deal

Ziff Davis Acquires theSkimm And Maxroll In Q1 To Expand Global Reach And Product Portfolio

HC Wainwright &amp; Co. analyst Mitchell Kapoor upgrades Sarepta Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) from Sell to Neutral and maintains the price target from $75 to $75.

Upgrades

SRPT

HC Wainwright & Co. Upgrades Sarepta Therapeutics to Neutral, Maintains Price Target to $75

BlackBerry Expects Q1 Total Revenue Of $107M-$115M Vs $127.99M Est, Adj EPS Of $(0.01)-Breakeven Vs $0.01 Est

DASH

Domino's Partners With DoorDash For Nationwide U.S. Launch In May 2025, Expanding To Canada Later

D. Boral Capital analyst Jesse Sobelson maintains PEDEVCO (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PED#AMEX">PED</a>) with a Buy and maintains $1.5 price target.

D. Boral Capital Maintains Buy on PEDEVCO, Maintains $1.5 Price Target

Renews highly coveted and valuable hockey rights long term Will deliver more national games and fewer blackouts to hockey fans Rogers is proud to remain the home of NHL&nbsp;hockey

NHL And Rogers Extend National Media Rights Partnership With 12-Year, $11B Agreement

Quest Diagnostics Launches New HPV Screening Solution To Enhance Cervical Cancer Risk Detection

Needham analyst Quinn Bolton reiterates D-Wave Quantum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) with a Buy and maintains $8.5 price target.

QBTS

Needham Reiterates Buy on D-Wave Quantum, Maintains $8.5 Price Target

The expanded spatial multiomic collaboration now includes automation of ACD's new RNAscope Multiomic LS Assay and protease-free workflows on Leica's BOND RX research staining instrument, further advancing the capabilities of spatial biology research.

Health Care

General

TECH

Bio-Techne Announced An Expansion Of The Longstanding Partnership Between Its Spatial Biology Brand, Advanced Cell Diagnostics And Leica Biosystems

By combining Rockwell's operational technology (OT) with AWS's advanced cloud services and global infrastructure, manufacturers will be equipped with scalable, secure, and flexible cloud solutions that help optimize asset performance, increase operational visibility, and deliver actionable insights from raw data.

Rockwell Automation, AWS Partner To Help Accelerate Manufacturing Through Advanced Industrial Automation Solutions

D. Boral Capital analyst Jason Kolbert maintains Scilex Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCLX#NASDAQ">SCLX</a>) with a Buy and lowers the price target from $22 to $18.

SCLX

D. Boral Capital Maintains Buy on Scilex Holding, Lowers Price Target to $18

Critical Metals Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRML#NASDAQ">CRML</a>) announced the results of an independent preliminary economic assessment (PEA) for its Tanbreez Project in southern Greenland, one of the largest <a target="_blank" href="https://www.benzinga.com/etfs/23/07/33233340/rare-earth-elements-explained" rel="noreferrer noopener">rare earth deposits</a> globally.
The PEA, conducted by Agricola Mining Consultants, estimates that just 1% of the project's 4.7 billion metric tons of host rock has a Net Present Value (NPV) of approximately $3 billion.
"Given the importance of rare earths for national security in the West and other next-generation technologies, I strongly believe there is a marked disconnect between the market valuation and long-term fundamentals of Critical Metals Corp. I look forward to progressing our plans for this world-class asset," <a target="_blank" href="https://www.criticalmetalscorp.com/news-releases/news-release-details/critical-metals-corps-tanbreez-valued-3-billion-irr-180-and" rel="noreferrer noopener">said</a> Tony Sage, Critical Metals' CEO and Chairman.
The Tanbreez Project, which holds a license until 2050, boasts an estimated 44.97 million metric tons of rare earth materials, grading at 0.40% Rare Earth Oxides and a substantial 27% concentration of Heavy Rare Earth Elements—crucial for defense, renewable energy, and advanced electronics.
The project's location in Southern Greenland offers deep-water access and relative proximity to existing infrastructure, making it a prime candidate for integration in the near-shore supply chains.
Critical Metals Corp plans to invest $10 million in further exploration and drilling by the end of this year. Once this investment is completed, the company can increase its equity stake from 42% to 92.5% by issuing additional shares worth $116 million.
The company aims to complete a Definitive Feasibility Study by the end of the year, which will provide further technical and economic validation of the project. The initial production target is 85,000 tons per annum of Rare Earth Oxides, with a possibility for a modular expansion plan to increase this output to 425,000 tons.
Greenland's mineral riches and strategic position in the Arctic region caught the interest of President Donald Trump, who expressed the desire to acquire the island. However, Greenland's new Prime Minister, Jens Frederik Nielsen, has firmly rejected this notion.
"President Trump says that the United States' will get Greenland.' Let me be clear: The United States will not get it. We do not belong to anyone else. We decide our own future," he <a target="_blank" href="https://www.facebook.com/Jensfrederiknielsendemokraatit" rel="noreferrer noopener">said</a> in a Facebook post on Sunday.
Price watch: Critical Metals Corp closed on Tuesday at $1.42. The stock is down 78.32% year-to-date.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44559190/gold-surges-past-3100-as-tariff-uncertainty-sets-the-silver-ratio-trade" target="_blank" rel="noreferrer noopener">Gold Surges Past $3,100 As Tariff Uncertainty Sets Silver Ratio Trade</a></li>
</ul>

Equities

Commodities

Small Cap

Legal

CRML

Critical Metals Corp Announces Multi-Billion Assessment For Its Greenland Project

NYAX

Nayax Acquires Inepro Pay To Strengthen Its Presence In The Benelux Region

Press Releases

NewGen Progresses Reverse Merger Plans with Engagement of Legal Teams and Updated Timeline

NewGen Launches Innovative Lifetime Egg Freezing Service to Address Growing Market Need in Asia

NewGen Announces Strategic Acquisition of MicroSort Reproductive Technology

NewGen Announces Reverse Stock Split

Management

NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director

NewGen Issues Clarification on Press Release Titled "NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director" dated February 20, 2025

NewGen Regains Compliance with Nasdaq Minimum Bid Price Requirement and Announces Listing Transfer to the Nasdaq Capital Market

NewGen and BOBCARE Announce Strategic Collaboration to Expand Fertility Services in Kyrgyzstan

NewGenIvf Provides Update on Proposed Reverse Merger with European Wellness Holdings and Completion of Strategic Acquisition of MicroSort Reproductive Technology

NewGenIVF Announces Termination of Proposed Reverse Merger Transaction with European Wellness

American Shared Hospital Services Common Stock

American Shared Hospital

Enzo Biochem, Inc. Common Stock ($0.01 Par Value)

Enzo Biochem

Kindly MD

Mobile-health Network Solutions - Class A Ordinary Shares

Mobile-health Network

ModivCare

MSP Recovery, Inc. - Class A Common Stock

MSP Recovery

NewGenIvf Group

Ontrak

P3 Health Partners Inc. - Class A Common Stock

P3 Health Partners

Prenetics Global Limited - Class A Ordinary Share

Prenetics Global

Precipio

SHL Telemedicine Ltd - American Depositary Shares

Comments

NewGenIvf Group

NewGenIvf Group (NIVF) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL